| Bruce Montgomerie, MD | |
|
3725 W 4100 S, West Valley City, UT 84120-5411 | |
| (801) 965-3600 | |
| (801) 965-3526 |
| Full Name | Bruce Montgomerie |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | 3725 W 4100 S, West Valley City, Utah |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780615153 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 1846081205 (Utah) | Primary |
| Entity Name | Permanente Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073606299 PECOS PAC ID: 8921910225 Enrollment ID: O20031104000710 |
News Archive
Retinal gene therapy could prevent loss of vision in patients with choroideremia and other retinal diseases, show the results of a phase I/II study.
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today announced that it has recently acquired direct ownership of technology for which it had previously exercised its option to exclusively license from Advirna LLC.
Researchers at the University of Cincinnati have received a five-year grant to develop rapid, robust, user-friendly diagnostics for influenza virus. An interdisciplinary team of scientists has received a $2.3 million dollar grant from the National Institute for Allergy and Infectious Diseases, one of the National Institutes of Health. The name of the grant is "Glycan Receptor Mimics for Rapid Detection, Typing, and Susceptibility Testing of Influenza."
The New York Times examines the controversy surrounding humanitarian aid to Syria, writing, "The United States and other international donors are spending hundreds of millions of dollars on humanitarian aid for Syrians afflicted by the civil war. But here in the rebel-controlled north, where the deprivation is most acute, that money has bought mostly anger and resentment: the vast majority of aid is going to territory controlled by President Bashar al-Assad, and the small amount reaching opposition-held areas is all but invisible."
Immunotherapy using monoclonal antibodies is a promising treatment strategy, and it might now be within reach: American scientists have successfully prepared an oligosaccharide enterobacterial antigen for which a monoclonal antibody has been developed. The study is published in the journal Angewandte Chemie.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Bruce Montgomerie, MD 3725 W 4100 S, West Valley City, UT 84120-5411 Ph: (801) 965-3600 | Bruce Montgomerie, MD 3725 W 4100 S, West Valley City, UT 84120-5411 Ph: (801) 965-3600 |
News Archive
Retinal gene therapy could prevent loss of vision in patients with choroideremia and other retinal diseases, show the results of a phase I/II study.
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today announced that it has recently acquired direct ownership of technology for which it had previously exercised its option to exclusively license from Advirna LLC.
Researchers at the University of Cincinnati have received a five-year grant to develop rapid, robust, user-friendly diagnostics for influenza virus. An interdisciplinary team of scientists has received a $2.3 million dollar grant from the National Institute for Allergy and Infectious Diseases, one of the National Institutes of Health. The name of the grant is "Glycan Receptor Mimics for Rapid Detection, Typing, and Susceptibility Testing of Influenza."
The New York Times examines the controversy surrounding humanitarian aid to Syria, writing, "The United States and other international donors are spending hundreds of millions of dollars on humanitarian aid for Syrians afflicted by the civil war. But here in the rebel-controlled north, where the deprivation is most acute, that money has bought mostly anger and resentment: the vast majority of aid is going to territory controlled by President Bashar al-Assad, and the small amount reaching opposition-held areas is all but invisible."
Immunotherapy using monoclonal antibodies is a promising treatment strategy, and it might now be within reach: American scientists have successfully prepared an oligosaccharide enterobacterial antigen for which a monoclonal antibody has been developed. The study is published in the journal Angewandte Chemie.
› Verified 9 days ago
Dr. Mary E Shapiro, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 3730 W 4700 S, West Valley City, UT 84118 Phone: 801-213-9200 | |
Mary Jane Pennington, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 3725 W 4100 South, West Valley City, UT 84120 Phone: 801-965-3600 Fax: 801-965-3526 | |
Dr. Ryan K Frome, D.O. Pediatrics Medicare: Medicare Enrolled Practice Location: 2965 W 3500 S, West Valley City, UT 84119 Phone: 801-965-3448 | |
Dr. Julie I Wilkerson, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3725 W 4100 S, West Valley City, UT 84120 Phone: 801-965-3600 Fax: 801-965-3526 | |
Alyson Eyre, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 2965 W 3500 S, West Valley City, UT 84119 Phone: 801-965-3600 | |
Dana C Ostermiller, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 3725 W 4100 S, West Valley City, UT 84120 Phone: 801-965-3600 | |
Craig A Brasher, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2965 W 3500 S, West Valley City, UT 84119 Phone: 801-965-3600 |